Rheumatology International

, Volume 34, Issue 1, pp 93–99 | Cite as

Results of a specific smoking cessation program for patients with arthritis in a rheumatology clinic

  • Antonio Naranjo
  • Ana Bilbao
  • Celia Erausquin
  • Soledad Ojeda
  • Félix M. Francisco
  • Iñigo Rúa-Figueroa
  • Carlos Rodríguez-Lozano
Original Article


The purpose of this study is to evaluate an intervention program in smoker patients. We selected consecutive active smoker patients with rheumatoid arthritis, spondyloarthritis, or connective tissue diseases. The intervention consisted of the following: (1) a baseline visit, which included verbal and written advice by the rheumatologist, emphasizing the practical benefits of smoking cessation. Patients completed a questionnaire that included smoking dependence tests and previous attempts to quit. (2) A follow-up visit to the nurse in the 3rd month for reinforcement and the receiving of pharmacological treatment to help patients quit smoking. The primary outcome was total abstinence in the last 7 days of a phone interview at 3, 6, and 12 months. The secondary outcome was a reduction in cigarette consumption by at least 50 %. A total of 945 patients were screened. About 185 (19.5 %) were current smokers, and 152 were included for intervention. In the previous 5 years, the mean annual withdrawal rate was 4.6 %. The smoking cessation rate was 11.8, 14.4, and 15.7 % at 3, 6, and 12 months (OR compared with previous cessation rate 3.8 (CI 95 % 1.8–8.1)). Twenty-nine patients (19 %) reduced ≥50 % of the cigarette consumption at 12 months. The linear regression analysis showed that a score of less dependence (p = 0.03) and previous attempts to quit smoking (p = 0.04) were significantly associated with definitive smoking cessation at 12 months. One out of six patients quit smoking with the aid of an educational program which included verbal and written advice by the rheumatologist and the nurse. As far as we know, this is the first interventional study in smoker patients with arthritis.


Rheumatoid arthritis Spondyloarthritis Ankylosing spondylitis Connective tissue diseases Lupus Vasculitis Patient education Smoking cessation Rheumatology nurse 


  1. 1.
    Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L (2004) Gene–environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 50:3085–3092PubMedCrossRefGoogle Scholar
  2. 2.
    Klareskog L, Padyukov L, Alfredsson L (2007) Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 19:49–54PubMedCrossRefGoogle Scholar
  3. 3.
    Klareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunewald J et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54:38–46PubMedCrossRefGoogle Scholar
  4. 4.
    Uhlig T, Hagen KB, Kvien TK (1999) Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. J Rheumatol 26:47–54PubMedGoogle Scholar
  5. 5.
    Costenbader KH, Feskanich D, Mandl LA, Karlson EW (2006) Smoking intensity, duration and cessation and the risk of rheumatoid arthritis in women. Am J Med 119:503–511PubMedCrossRefGoogle Scholar
  6. 6.
    Karlson EW, Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH (1999) A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 42:910–917PubMedCrossRefGoogle Scholar
  7. 7.
    Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, Alfredsson L (2003) EIRA study group. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 62:835–841PubMedCrossRefGoogle Scholar
  8. 8.
    Naranjo A, Toloza S, da Silveira IG, Lazovskis J, Hetland ML, Hamoud H et al (2010) Smokers and non smokers with rheumatoid arthritis have similar clinical status: data from the multinational QUEST-RA database. Clin Exp Rheumatol 28:820–827PubMedGoogle Scholar
  9. 9.
    Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C (2010) Predictors for remission in rheumatoid arthritis patients: a systematic review. Arthritis Care Res 62:1128–1143CrossRefGoogle Scholar
  10. 10.
    van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D et al (2009) Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. Arthritis Rheum 60:2262–2271PubMedCrossRefGoogle Scholar
  11. 11.
    Ruiz-Esquide V, Gómez-Puerta JA, Cañete JD, Graell E, Vazquez I, Ercilla MG et al (2011) Effects of smoking on disease activity and radiographic progression in early rheumatoid arthritis. J Rheumatol 38:2536–2539PubMedCrossRefGoogle Scholar
  12. 12.
    Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DP (2002) Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 46:2010–2019PubMedCrossRefGoogle Scholar
  13. 13.
    González-Gay MA, González-Juanatey C (2009) Cardiovascular disease in rheumatoid arthritis. Importance and clinical management. Reumatol Clin 5:95–97PubMedCrossRefGoogle Scholar
  14. 14.
    Wallberg-Jonsson S, Ohman ML, Dahlqvist SR (1997) Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 24:445–451PubMedGoogle Scholar
  15. 15.
    Naranjo A, Sokka T, Descalzo MA, Calvo-Alén J, Hørslev-Petersen K, Luukkainen RK et al (2008) Cardiovascular disease in patients with rheumatoid arthritis. Results from the QUEST-RA study. Arthritis Res Ther 10:R30PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Freemer MM, King TE Jr, Criswell LA (2006) Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Ann Rheum Dis 65:581–584PubMedCrossRefGoogle Scholar
  17. 17.
    Bourré-Tessier J, Peschken CA, Bernatsky S, Joseph L, Clarke AE, Fortin PR et al (2013) Smoking is associated with cutaneous manifestations in systemic lupus erythematosus. Arthritis Care Res (Hoboken). doi:10.1002/acr.21966. [Epub ahead of print]
  18. 18.
    Turchin I, Bernatsky S, Clarke AE, St-Pierre Y, Pineau CA (2009) Cigarette smoking and cutaneous damage in systemic lupus erythematosus. J Rheumatol 36:2691–2693PubMedCrossRefGoogle Scholar
  19. 19.
    Kreuter A, Gaifullina R, Tigges C, Kirschke J, Altmeyer P, Gambichler T (2009) Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking. Arch Dermatol 145:244–248PubMedGoogle Scholar
  20. 20.
    Ho KT, Ahn CW, Alarcón GS, Baethge BA, Tan FK, Roseman J et al (2005) Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII.Factors predictive of thrombotic events. Rheumatology (Oxford) 44:1303–1307CrossRefGoogle Scholar
  21. 21.
    Ward MM, Hendrey MR, Malley JD, Learch TJ, Davis JC Jr, Reveille JD, Weisman MH (2009) Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Rheum 61:859–866PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Poddubnyy D, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J et al (2012) Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 64:1388–1398PubMedCrossRefGoogle Scholar
  23. 23.
    Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325–331PubMedCrossRefGoogle Scholar
  24. 24.
    Stead LF, Bergson G, Lancaster T (2008) Physician advice for smoking cessation. Cochrane Database Syst Rev CD000165Google Scholar
  25. 25.
    Prochaska JO, DiClemente CC (1983) Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 51:390–395PubMedCrossRefGoogle Scholar
  26. 26.
    Becoña E, Gómez-Durán B, Alvarez-Soto E, García MP (1992) Scores of Spanish smokers on Fagerström’s Tolerance Questionnaire. Psychol Rep 71(3 Pt2):1227–1233PubMedCrossRefGoogle Scholar
  27. 27.
    Richmond RL, Kehoe LA, Webster IW (1993) Multivariate models for predicting abstention following intervention to stop smoking by general practitioners. Addiction 88:1127–1135PubMedCrossRefGoogle Scholar
  28. 28.
    Urowitz MB, Gladman D, Ibañez D, Fortin P, Sanchez-Guerrero J, Bae S et al (2007) Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus 16:731–735PubMedCrossRefGoogle Scholar
  29. 29.
    Fisher MC, Hochberg MC, El-Taha M, Kremer JM, Peng C, Greenberg JD (2012) CORRONA Investigators. Smoking, smoking cessation, and disease activity in a large cohort of patients with rheumatoid arthritis. J Rheumatol 39:904–909PubMedCrossRefGoogle Scholar
  30. 30.
    Andersson ML, Bergman S, Söderlin MK (2012) The effect of stopping smoking on disease activity in rheumatoid arthritis (RA). Data from BARFOT, a multicenter study of early RA. Open Rheumatol J 6:303–309PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    van den Broek M, Klarenbeek NB, Dirven L, van Schaardenburg D, Hulsmans HM, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF (2011) Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. Ann Rheum Dis 70:1389–1394PubMedCrossRefGoogle Scholar
  32. 32.
    Chung HY, Machado P, van der Heijde D, D’Agostino MA, Dougados M (2012) Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, infl ammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis 71:809–816PubMedCrossRefGoogle Scholar
  33. 33.
    Solomon DH, Peters MJ, Nurmohamed MT, Dixon W (2013) Data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritis. Arthritis Rheum 65:1675–1683PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Soubrier M, Perrodeau E, Gaudin P, Cantagrel A, Le Loët X, Flipo R et al (2013) Impact of a nurse led program on the management of comorbidities in rheumatoid arthritis (RA). Results of a prospective, multicentre, randomized, controlled trial (COMEDRA). Ann Rheum Dis 72(Suppls3):131Google Scholar
  35. 35.
    Gordon MM, Thomson EA, Madhok R, Capell HA (2002) Can intervention modify adverse lifestyle variables in a rheumatoid population? Results of a pilot study. Ann Rheum Dis 61:66–69PubMedCrossRefGoogle Scholar
  36. 36.
    O’Neill SG, Pego-Reigosa JM, Hingorani AD, Bessant R, Isenberg DA, Rahman A (2009) Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford) 48:573–575CrossRefGoogle Scholar
  37. 37.
    Harris H (2013) How can we persuade patients with rheumatoid arthritis to stop smoking? Ann Rheum Dis 72(Suppls3):3Google Scholar
  38. 38.
    Pérez Trullén A, Herrero I, Clemente ML, Escosa L (2004) Abordaje de la prevención y el tratamiento del tabaquismo: ¿a quién, cuándo y cómo realizar la deshabituación tabáquica? Arch Bronconeumol 40(Supl 3):63–73Google Scholar
  39. 39.
    Hollis JF, Lichtenstein E, Vogt TM, Stevens VJ, Biglan A (1993) Nurse-assisted counseling for smokers in primary care. Ann Intern Med 118(7):521–525PubMedCrossRefGoogle Scholar
  40. 40.
    Rice VH, Stead LF (2008) Nursing interventions for smoking cessation. Cochrane Database Syst Rev 23(1):CD001188Google Scholar
  41. 41.
    Hettema J, Steele J, Miller WR (2005) Motivational interviewing. Annu Rev Clin Psychol 1:91–111PubMedCrossRefGoogle Scholar
  42. 42.
    Lai DT, Cahill K, Qin Y, Tang JL (2010) Motivational interviewing for smoking cessation. Cochrane Database Syst Rev CD006936Google Scholar
  43. 43.
    Carpenter MJ, Hughes JR, Solomon LJ, Callas PW (2004) Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol 72:371–378PubMedCrossRefGoogle Scholar
  44. 44.
    PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary (2008). Respir Care 53:1217–22Google Scholar
  45. 45.
    Nerín I, Novella P, Crucelaegui A, Beamonte A, Sobradiel N, Gargallo P (2004) Factores predictores de éxito a los seis meses en fumadores tratados en una Unidad de Tabaquismo. Arch Bronconeumol 40:558–562PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Antonio Naranjo
    • 1
  • Ana Bilbao
    • 1
  • Celia Erausquin
    • 1
  • Soledad Ojeda
    • 1
  • Félix M. Francisco
    • 1
  • Iñigo Rúa-Figueroa
    • 1
  • Carlos Rodríguez-Lozano
    • 1
  1. 1.Department of Rheumatology, Hospital Universitario de Gran Canaria Dr. NegrínUniversidad de Las Palmas de Gran CanariaLas Palmas de Gran CanariaSpain

Personalised recommendations